"This therapy is currently available for patients with blood cancer, and we want to investigate if we can use the method to treat ovarian cancer," says the study's joint last author…
The first-of-its-kind Cancer Loyalty Card Study (CLOCS) study looked at whether there is a link between a diagnosis of ovarian cancer and a history of buying over-the-counter pain and…
Researchers have developed a novel genetic test to discover ovarian cancer patients who benefit from PARP inhibitors. PARP inhibitors are a type of targeted drug that could be effective…
The Phase 2 multicenter, open-label combination trial builds upon the promising results of monotherapeutic activity of ONC-392 seen in previous clinical trial ONC-392 is the first known…